Search Results - "Fagel, Nick D."

The Prognostic Value of Biomarkers in Non-ST-Elevation Acute Coronary Syndrome Patients that are Treated by an Early Invasive Strategy: Insights from the OPTIMA-2 Trial by Fagel, Nick D, Vink, Maarten A, Heestermans, Antonius A C M, Riezebos, Robert K

“…Patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) consists of a heterogenic population and improvement in identification of a specific risk…”
Get full text

Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction: The REVELATION Randomized Trial by Vos, Nicola S, Fagel, Nick D, Amoroso, Giovanni, Herrman, Jean-Paul R, Patterson, Mark S, Piers, Lieuwe H, van der Schaaf, René J, Slagboom, Ton, Vink, Maarten A

“…This study sought to assess the efficacy and safety of a drug-coated balloon (DCB) strategy versus drug-eluting stent (DES) in primary percutaneous coronary…”
Get full text

Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial by Raju, Nina C., Yi, Qilong, Nidorf, Mark, Fagel, Nick D., Hiralal, Rajesh, Eikelboom, John W.

“…There is a need for more effective therapies to reduce morbidity and mortality from cardiovascular disease. Inflammation plays a central role in the…”
Get full text

An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: The OPTIMA-2 randomized controlled trial by Fagel, Nick D., Amoroso, Giovanni, Vink, Maarten A., Slagboom, Ton, van der Schaaf, René J., Herrman, Jean-Paul, Patterson, Mark S., Oosterwerff, Erik F.J., Vos, Nicola S., Verheugt, Freek W.A., Tijssen, Jan G.P., de Winter, Robbert J., Riezebos, Robert K.

“…In intermediate- and high-risk non-ST elevated acute coronary syndrome (NSTE-ACS) patients, a routine invasive approach is recommended. The timing of coronary…”
Get full text

One‐year mortality in NSTEMI patients is unaffected by timing of PCI within the first week of admission: Results of a real‐world cohort analysis by Fagel, Nick D., Amoroso, Giovanni, Rabbering, Tanja, Gescher, Froukje, Vink, Maarten A., Slagboom, Ton, Schaaf, René J., Herrman, Jean‐Paul R., Patterson, Mark S., Vos, Nicola S., Verbeek, Eva C., Winter, Robbert J., Riezebos, Robert K.

“…Objectives We aimed to explore the impact of time to percutaneous coronary intervention (PCI) (T2P) on 1‐year mortality in non‐ST‐elevation myocardial…”
Get full text

Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction by Vos, Nicola S., Fagel, Nick D., Amoroso, Giovanni, Herrman, Jean-Paul R., Patterson, Mark S., Piers, Lieuwe H., van der Schaaf, René J., Slagboom, Ton, Vink, Maarten A.

“…This study sought to assess the efficacy and safety of a drug-coated balloon (DCB) strategy versus drug-eluting stent (DES) in primary percutaneous coronary…”
Get full text

The Effect of the Timing of Invasive Management on Cardiac Function in Patients with NSTE-ACS, Insights from the OPTIMA-2 Randomized Controlled Trial by Fagel, Nick D., Leuven, Stefan G. J., Kikkert, Wouter J., de Leau, Michelle M., van Heerebeek, Loek, Riezebos, Robert K.

“…The timing of coronary angiography in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) remains a matter of debate. The relationship between…”
Get full text

Effects of a nurse-coordinated prevention programme on health-related quality of life and depression in patients with an acute coronary syndrome: results from the RESPONSE randomised controlled trial by Jørstad, Harald T, Minneboo, Madelon, Helmes, Harold J M, Fagel, Nick D, Scholte Op Reimer, Wilma J, Tijssen, Jan G P, Peters, Ron J G

“…Improvement of health-related quality of life (HRQOL) is an important goal in preventive cardiology. HRQOL is also related to depressive symptoms, which…”
Get full text

Abstract 10164: Stent Thrombosis With and Without Aspirin After Pci in Patients With Atrial Fibrillation by Fagel, Nick D, Herrman, Jean-Paul R, Verheugt, Freek

“…BackgroundTriple therapy (oral anticoagulants, P2Y12 blocker and aspirin, TT) after PCI in atrial fibrillation (AF) is associated with increased bleeding. Four…”
Get full text